癌症：一个多面的敌人和精准肿瘤学的应对。
Cancer: A Multifaceted Enemy and the Precision Oncology Response.
机构信息
Institute of Biomedical Technologies, National Research Council (CNR), Area della Ricerca di Pisa, 56124 Pisa, Italy.
出版信息
Int J Mol Sci. 2024 May 21;25(11):5577. doi: 10.3390/ijms25115577.
Abstract
Cancer heterogeneity presents a major obstacle in clinical practice that grants tumor cells remarkable levels of resilience, adaptability, and invasiveness [...].
摘要
癌症异质性是临床实践中的一个主要障碍，它赋予肿瘤细胞显著的韧性、适应性和侵袭性[...]。
相似文献
1
Cancer: A Multifaceted Enemy and the Precision Oncology Response.癌症：一个多面的敌人和精准肿瘤学的应对。
Int J Mol Sci. 2024 May 21;25(11):5577. doi: 10.3390/ijms25115577.
2
Precision oncology: East meets West.精准肿瘤学：东方与西方的交汇
Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4.
3
Perspective on Precision Medicine in Oncology.肿瘤精准医学的思考。
Pharmacotherapy. 2017 Sep;37(9):988-989. doi: 10.1002/phar.1975. Epub 2017 Aug 7.
4
CRISPR-Cas13a system: a novel approach to precision oncology.CRISPR-Cas13a系统：精准肿瘤学的一种新方法。
Cancer Biol Med. 2020 Feb 15;17(1):6-8. doi: 10.20892/j.issn.2095-3941.2019.0325.
5
Giving Up on Precision Oncology? Not So Fast!放弃精准肿瘤学？没那么快！
Clin Transl Sci. 2017 May;10(3):128-129. doi: 10.1111/cts.12457. Epub 2017 Feb 21.
6
Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.通过协作的蛋白质基因组学和数据共享，推动精准肿瘤学的革命。
Cell. 2018 Apr 19;173(3):535-539. doi: 10.1016/j.cell.2018.04.008.
7
Evolving Paradigms of Personalized Medicine in Oncology.肿瘤学中个性化医疗的不断演变的范式
Natl Med J India. 2017 Nov-Dec;30(6):305-308. doi: 10.4103/0970-258X.239068.
8
Delivering on the promise of precision cancer medicine.兑现精准癌症医学的承诺。
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
9
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.《2017年临床癌症进展：美国临床肿瘤学会抗癌进展年度报告》
J Clin Oncol. 2017 Apr 20;35(12):1341-1367. doi: 10.1200/JCO.2016.71.5292. Epub 2017 Feb 1.
10
Genomic Medicine Takes the Stage, Again!基因组医学再度登上舞台！
J Natl Compr Canc Netw. 2018 Jul;16(7):795. doi: 10.6004/jnccn.2018.0063.
本文引用的文献
1
Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers.在人类癌症中，增强 TP53 突变非依赖性的细胞凋亡。
Int J Mol Sci. 2024 Apr 23;25(9):4600. doi: 10.3390/ijms25094600.
2
Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study.腔面B型乳腺癌的染色体不稳定模式与克隆异质性：一项初步研究
Int J Mol Sci. 2024 Apr 19;25(8):4478. doi: 10.3390/ijms25084478.
3
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology. annexin A5 在人类生理病理中的相关性、可预测性和实用性。
Int J Mol Sci. 2024 Mar 1;25(5):2865. doi: 10.3390/ijms25052865.
4
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.利用种系 BRCA1 杂合不足与 PARP 抑制在 JAK2V617F 阳性骨髓增殖性肿瘤中的合成致死性
Int J Mol Sci. 2023 Dec 16;24(24):17560. doi: 10.3390/ijms242417560.
5
Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment.解析结缔组织生长因子作为治疗靶点，并评估咖啡醇作为三阴性乳腺癌治疗的潜在药物候选物。
Int J Mol Sci. 2023 Nov 14;24(22):16307. doi: 10.3390/ijms242216307.
6
Uncovering NOTCH1 as a Promising Target in the Treatment of -Rearranged Leukemia.揭示 NOTCH1 作为治疗 - 重排白血病的有希望的靶点。
Int J Mol Sci. 2023 Sep 23;24(19):14466. doi: 10.3390/ijms241914466.
7
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.USP7 抑制通过诱导 p53 介导的细胞凋亡和 EZH2、N-Myc 下调抑制神经母细胞瘤生长。
Int J Mol Sci. 2023 Sep 7;24(18):13780. doi: 10.3390/ijms241813780.
8
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.癌症的靶向治疗：从正在进行的临床试验到 FDA 批准的药物。
Int J Mol Sci. 2023 Sep 3;24(17):13618. doi: 10.3390/ijms241713618.
9
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.FOXM1、MEK 和 CDK4/6：恶性外周神经鞘瘤治疗的新靶点。
Int J Mol Sci. 2023 Sep 2;24(17):13596. doi: 10.3390/ijms241713596.
10
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets.BCG 无应答性非肌肉浸润性膀胱癌：当前治疗现状与新型新兴分子靶点。
Int J Mol Sci. 2023 Aug 9;24(16):12596. doi: 10.3390/ijms241612596.
Zotero 插件